Many of my patients suffering BPH symptoms are drawn to the UroLift treatment because of its simplicity and rapid recovery time
Raleigh, N.C. (PRWEB) August 29, 2017
John Kaspar, M.D., today announced that his 100th patient has been treated with the UroLift® System, a proven, minimally invasive technology to treat men suffering from symptoms associated with Benign Prostatic Hyperplasia, or BPH. Dr. Kaspar is the first physician in Raleigh to reach this milestone, performing more UroLift System treatments than any other doctor in the area. In May, Dr. Kaspar was named the first UroLift Center of Excellence in the state of North Carolina.
“Many of my patients suffering BPH symptoms are drawn to the UroLift treatment because of its simplicity and rapid recovery time,” said Dr. Kaspar. “The UroLift System offers multiple benefits that are important to my patients including preservation of sexual function and the ability to discontinue use of medications. Perhaps best of all, it can be done in an office setting in under and hour.”
Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.
Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring additional treatment for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.
Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.
About the UroLift System
NeoTract’s FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the treatment. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com
About Associated Urologists of North Carolina, PA
Associated Urologists of North Carolina is one of the largest urology specialty group practices in North Carolina. With 15 board-certified urologists, AUNC has served the North Carolina region for many years and for many more to come. Providing the most advanced, comprehensive and specialized urology treatment options for male, female, and pediatric urological problems across eight locations. Engaging with the Clinical Research industry for more than thirty years, AUNC has operated and executed more than fifty urological and related studies. These research studies offer our patients medical alternatives and different procedures in the management of their health care. Are you looking for the best urology care in your area? Learn more at http://www.auncurology.com.
To schedule a consultation with Dr. Kaspar, please call 919-390-7373.
# # #
1 Roehrborn et al. EAU Abstract_ Eur Urol Suppl 2017; 16(3):e192.
2 Sonksen et al J Urology 2016